ClinicalTrialsFinder

Hemophagocytic Lymphohistiocytosis Clinical Trials in Amsterdam, Noord-Holland - NET

1 recruitingAmsterdam, Noord-Holland - NET, Netherlands

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Electra Therapeutics Inc.156 enrolled40 locationsNCT05416307